GT-1620

N/A

Report date: 2022/07/26 16:50:18
NME

Base Information

Drug NameGT-1620
Drug Alias NameGT-1620
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A